Retatrutides safety profile is consistent with whats already been observed GLP-1 receptor agonists and combined GLP-1/GIP receptor agonists, meaning the expected side effects are primarily gastrointestinal (GI) in nature: Nausea, vomiting, diarrhea, and constipation
Non-invasive options include Cologuard, a stool-based DNA test detecting altered DNA and blood, with 93.9% sensitivity for detecting colon cancer
This allows for faster transit through the stomach and less interference from other food particles
Pain: Length of Treatment: Length of Recovery: Number of Treatments: The number of treatments will vary, depending on patient needs.
It is recommended that after you open, or use a vial of bacteriostatic water, that you dispose of it after 28 days